On this page
Larotrectinib
Active ingredient 3 prescription 3 with labelling
Overview
Source: NDC DirectoryIngredient name
LAROTRECTINIB
Base moiety
LAROTRECTINIB
RxNorm CUI
UNII
PF9462I9HX
Medication products
5
Brand names
1
Dosage forms
4
FAERS reports
874 · not a risk measure
- larotrectinib Capsule
- larotrectinib Liquid
- VITRAKVI Larotrectinib · Solution
- VITRAKVI Larotrectinib · Capsule
- VITRAKVI Larotrectinib · Solution, Concentrate
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Capsule | 2 | larotrectinib, VITRAKVI |
| Liquid | 1 | larotrectinib |
| Solution | 1 | VITRAKVI |
| SOLUTION, Concentrate | 1 | VITRAKVI |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |